Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine

Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challengin...

Descripción completa

Detalles Bibliográficos
Autores principales: AlQudari, Elham A, Alabdan, Lulwah I, Alkhathami, Abdulla A, Alotaibi, Mohammed D, Alhamzi, Hanan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844483/
https://www.ncbi.nlm.nih.gov/pubmed/35186544
http://dx.doi.org/10.7759/cureus.21279
_version_ 1784651486931714048
author AlQudari, Elham A
Alabdan, Lulwah I
Alkhathami, Abdulla A
Alotaibi, Mohammed D
Alhamzi, Hanan A
author_facet AlQudari, Elham A
Alabdan, Lulwah I
Alkhathami, Abdulla A
Alotaibi, Mohammed D
Alhamzi, Hanan A
author_sort AlQudari, Elham A
collection PubMed
description Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challenging case of adult-onset Still's disease in a patient who recently received the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca).
format Online
Article
Text
id pubmed-8844483
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88444832022-02-17 Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine AlQudari, Elham A Alabdan, Lulwah I Alkhathami, Abdulla A Alotaibi, Mohammed D Alhamzi, Hanan A Cureus Internal Medicine Adult-onset Still's disease (AOSD) is a rare autoimmune disorder without clear etiology. It is known that genetic and infectious causes trigger diseases. AOSD cases have been reported after coronavirus disease 2019 (COVID-19) infection and post influenza vaccine. Here, we report this challenging case of adult-onset Still's disease in a patient who recently received the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca). Cureus 2022-01-15 /pmc/articles/PMC8844483/ /pubmed/35186544 http://dx.doi.org/10.7759/cureus.21279 Text en Copyright © 2022, AlQudari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
AlQudari, Elham A
Alabdan, Lulwah I
Alkhathami, Abdulla A
Alotaibi, Mohammed D
Alhamzi, Hanan A
Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
title Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
title_full Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
title_fullStr Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
title_full_unstemmed Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
title_short Adult-Onset Still’s Disease After the ChAdOx1 nCoV-19 Vaccine
title_sort adult-onset still’s disease after the chadox1 ncov-19 vaccine
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844483/
https://www.ncbi.nlm.nih.gov/pubmed/35186544
http://dx.doi.org/10.7759/cureus.21279
work_keys_str_mv AT alqudarielhama adultonsetstillsdiseaseafterthechadox1ncov19vaccine
AT alabdanlulwahi adultonsetstillsdiseaseafterthechadox1ncov19vaccine
AT alkhathamiabdullaa adultonsetstillsdiseaseafterthechadox1ncov19vaccine
AT alotaibimohammedd adultonsetstillsdiseaseafterthechadox1ncov19vaccine
AT alhamzihanana adultonsetstillsdiseaseafterthechadox1ncov19vaccine

Ejemplares similares